Icon

TOPICORT - (0.25%; Spray, Topical)

DESOXIMETASONE Sun (Taro)
0.25%; Spray, Topical
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
Less Than 5
Less Than 5
Used to treat a type of skin condition (plaque psoriasis). It reduces the swelling, itching, and redness that may occur with plaque psoriasis. This medication is a strong corticosteroid.
Yes
******* ** *** ***** ** **** **** ** **** ******* ******* - *** *, **** ; *,***,*** - *** **, **** *** *** ************ *********. ****** *** ****** ** ** ****** ****, ********** *** ******* **** ******* *** ***** ** ***** *** *** *****. ** ** ********* ** **** **** ***** ** ******* ****** ********** *** **** ***** ******* ** *** **, **** ***** ** *** ********** ** *******. ********* ******* ****** ****** ******* ****** ***** **, ****. ** ****** ******* ** ****** ******** ***** *** **, **** ** *** ***** ****** *** *** ******* *** ******* **** ****. ******* ***** & ******** ***** **** ** **** **** ****** ** ******* *** **** ************ *********. ****** ** ****** **** **** ***** ****** **** ***** *** ***** ****** *********** ****** *** *******, ***(****) ***** * *** ******* ***** ***** *** ******, *** ****** *** *** **** ** *** ************** *** ** ****** ***** ***** ** ******** ** ****** *** *******. ***** ** **** ******** ******* ** **** **, ****. *****, ********** ********* **** *****. ******* ******** **** ******* ** *** **, ****. **** ****** **** ******* **** ********. ***** *** ***** ** ********** *** *** *****. ******** **** ****** ******* ***** ******* ********.
TOPICORT Patent 1 Patent 2 Patent 3
******* ******* ******* *******
***** ******* ******* *******
******** ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* *** \ ** *** **, **** ******* ******** ******** ** *** **, ****
***** ** \ ** **** **, **** ******* ******** ******** ** **** **, ****
******** ** \ ** *** *, **** ******* **** ****** **** ********
  1. *** **, **** : **** ***** * **** ******* ******* ** ******* (**, **, ******) ***** * **** ** **** ******* ******* - *** *, **** ; *,***,*** - *** **, ****.
  2. *** **, **** : ********** *** ******* **** ******* ***** *** ***** ** ********** *** *** *****.
  3. *** **, **** : **** ***** * **** ******* ***** ** ***** ***** **** ** **** ******* ******* - *** *, **** ; *,***,*** - *** **, ****.
  4. *** **, **** : **** ***** * ****** *** *** ******* *****.
  5. *** *, **** : *** ******* ***** ******.
  6. *** *, **** : **** ***** * **** ******* ******** ***** **** ** **** ******* ******* - *** *, **** ; *,***,*** - *** **, ****.
  7. *** *, **** : ********** *** ********* **** *****, ***** *** ***** ** ********* *** *** *****.
  8. *** **, **** : **** ****** ******* **** ********, ***** *** ***** ** ********** *** *** *****.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.